Literature DB >> 558046

Thymomas.

D P LeGolvan, M R Abell.   

Abstract

Forty-six thymomas, defined as neoplasms of thymic epithelium, were assessed in respect to histologic type, clinical manifestations and end results. Twenty-three were lymphoepithelial, 12 epithelial, and 11 spindled cell tumors. The sex distribution for all thymomas was approximately equal for males and females but the lymphoepithelial tumors were more common in females and the epithelial tumors more common in males. There was no distribution difference in sex for the spindled cell thymomas which occurred much later in life than the other types. Twenty-five percent of patients were asymptomatic, the tumors being discovered on roentgenograms done on a routine basis or for an unrelated purpose. The most common presenting symptoms were related to myasthenia gravis, and symptoms due to pressure on mediastinal structures were next in frequency. Other endocrine abnormalities were present in 20% of patients. Two male patients also had carcinomas of the thyroid gland. Twenty thymomas were infiltrative tumors having invaded the adjacent mediastinum. There were no examples of extrathoracic spread. Twelve of 16 patients with myasthenia gravis had lymphoepithelial thymomas and four epithelial thymomas. There were no cases of myasthenia gravis in patients with spindled cell thymomas. The crude five-year survival rate was 65%. Only 17% of patients died as a result of recurrent and infiltrative thymomas; the other 18% of patients died from a variety of causes not directly related to the thymomas. The epithelial type of thymoma tended to be more extensive and to pursue a more aggressive course but histologic classification was of little value in predicting final outcome. Poor prognosis is more closely associated with tumors having an infiltrative character. Classification is of importance, however, in alerting the clinician to certain associated diseases.

Entities:  

Mesh:

Year:  1977        PMID: 558046     DOI: 10.1002/1097-0142(197705)39:5<2142::aid-cncr2820390531>3.0.co;2-q

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  12 in total

1.  A spectrum of thymomas over a three year period.

Authors:  M Bolster; W Kealy
Journal:  Ir J Med Sci       Date:  1988-11       Impact factor: 1.568

2.  Intrathyroidal epithelial thymoma: an entity distinct from squamous cell carcinoma of the thyroid.

Authors:  A Miyauchi; K Kuma; F Matsuzuka; S Matsubayashi; A Kobayashi; H Tamai; S Katayama
Journal:  World J Surg       Date:  1985-02       Impact factor: 3.352

3.  Metastatic thymoma involving the bone marrow.

Authors:  Mhair Dekmezian; Stella Wenceslao; John R Krause
Journal:  Proc (Bayl Univ Med Cent)       Date:  2016-01

Review 4.  Thymic neoplasms: a clinical update.

Authors:  Mark Mikhail; Yasmin Mekhail; Tarek Mekhail
Journal:  Curr Oncol Rep       Date:  2012-08       Impact factor: 5.075

5.  The diagnosis of thymoma in myasthenia gravis.

Authors:  J A Aarli
Journal:  Ital J Neurol Sci       Date:  1983-12

6.  Non-invasive thymoma with widespread blood-borne metastasis.

Authors:  A Yoshida; T Shigematsu; H Mori; H Yoshida; R Fukunishi
Journal:  Virchows Arch A Pathol Anat Histol       Date:  1981

7.  [A comparative clinical and pathological study on the classification and prognostic features of 57 thymomas. I. Microscopy and ultrastructural pathology (author's transl)].

Authors:  H F Otto; H Hüsselmann
Journal:  Z Krebsforsch Klin Onkol Cancer Res Clin Oncol       Date:  1978-01-26

8.  Thymoma and thymic carcinoma. Relation of thymoma epithelial cells to the cortical and medullary differentiation of thymus.

Authors:  M Marino; H K Müller-Hermelink
Journal:  Virchows Arch A Pathol Anat Histopathol       Date:  1985

9.  Radiologic evaluation of the thymus in juvenile myasthenia gravis.

Authors:  A S Thurmond; R C Brasch
Journal:  Pediatr Radiol       Date:  1978-09-26

10.  Congestive heart failure associated with thymoma in two nubian goats.

Authors:  C M Rostkowski; T Stirtzinger; J D Baird
Journal:  Can Vet J       Date:  1985-09       Impact factor: 1.008

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.